# Mycopharmacology Unified Knowledge Graph
## CroweLogic-Pharma's Unique Framework for Mushroom Drug Discovery

**Based on**: The Data Developers' Unified Biomedical Knowledgebase
**Specialized for**: Mushroom-derived therapeutics and natural product drug discovery
**Innovation**: First unified knowledge base connecting cultivation → bioactives → targets → clinical outcomes

---

## Executive Summary

### The Problem
Mushroom pharmaceutical research faces unique challenges:
- **Fragmented Data**: Cultivation data, bioactive compounds, protein targets, and clinical trials exist in separate silos
- **Lost Connections**: The link between cultivation parameters and therapeutic outcomes is rarely tracked
- **Manual Integration**: Researchers spend 80% of time connecting mushroom cultivation data with pharmaceutical databases
- **Reproducibility Crisis**: Lack of standardized data makes it difficult to replicate successful compounds

### Our Solution: Mycopharmacology Knowledge Graph

We extend the proven Unified Biomedical Knowledgebase framework by adding **four critical mycology-specific layers**:

1. **Mushroom Cultivation Database** (NEW)
2. **Fungal Metabolomics Database** (NEW)
3. **Traditional Use Knowledge Base** (NEW)
4. **Environmental-Bioactivity Correlations** (NEW)

Combined with standard pharmaceutical databases:
5. **ChEMBL** (bioactivity)
6. **UniProt** (proteomics)
7. **PubMed/PMC** (literature)
8. **ClinicalTrials.gov** (clinical data)

---

## Architecture Overview

```
┌─────────────────────────────────────────────────────────────────────┐
│                 MYCOPHARMACOLOGY KNOWLEDGE GRAPH                     │
│                         (Unified Query Layer)                        │
└─────────────────────────────────────────────────────────────────────┘
                                   │
                    ┌──────────────┴──────────────┐
                    │                             │
        ┌───────────▼──────────┐      ┌──────────▼────────────┐
        │  MYCOLOGY LAYER      │      │  PHARMACEUTICAL LAYER  │
        │  (Unique to Us)      │      │  (Standard)            │
        └───────────┬──────────┘      └──────────┬─────────────┘
                    │                            │
        ┌───────────┴──────────┐     ┌──────────┴─────────────┐
        │                      │     │                        │
   ┌────▼─────┐         ┌─────▼────┐│ ┌──────┐  ┌────────┐  │
   │Cultivation│         │ Fungal   ││ │ChEMBL│  │UniProt │  │
   │ Database  │         │Metabolites││ │      │  │        │  │
   └────┬──────┘         └─────┬────┘│ └──┬───┘  └───┬────┘  │
        │                      │     │    │          │        │
   ┌────▼──────┐        ┌──────▼────┐│ ┌──▼──────────▼────┐  │
   │Traditional │        │Env-Bioact ││ │  PubMed/PMC      │  │
   │   Use KB   │        │Correlations││ │  ClinicalTrials  │  │
   └────────────┘        └───────────┘│ └──────────────────┘  │
                                      └──────────────────────────┘

                    ┌────────────────────────┐
                    │   AI INFERENCE LAYER   │
                    │  (CroweLogic-Pharma)   │
                    └────────────────────────┘
```

---

## Schema Design

### 1. Mushroom Cultivation Database (NEW)

**Core Tables**:

```sql
CREATE TABLE cultivation_runs (
    run_id VARCHAR(50) PRIMARY KEY,
    species VARCHAR(100),
    strain_id VARCHAR(50),
    substrate_type VARCHAR(100),
    substrate_composition JSONB,
    temperature_profile JSONB,
    humidity_profile JSONB,
    co2_levels JSONB,
    light_conditions JSONB,
    incubation_duration INT,
    fruiting_duration INT,
    yield_kg DECIMAL(10,2),
    cultivation_facility VARCHAR(100),
    date_started DATE,
    date_harvested DATE,
    FOREIGN KEY (species) REFERENCES mushroom_species(species_id)
);

CREATE TABLE bioactive_measurements (
    measurement_id VARCHAR(50) PRIMARY KEY,
    run_id VARCHAR(50),
    compound_name VARCHAR(100),
    compound_class VARCHAR(50),
    concentration_mg_per_g DECIMAL(10,4),
    extraction_method VARCHAR(100),
    analysis_method VARCHAR(50), -- HPLC, LC-MS, etc.
    measurement_date DATE,
    FOREIGN KEY (run_id) REFERENCES cultivation_runs(run_id),
    FOREIGN KEY (compound_name) REFERENCES compounds(compound_id)
);

CREATE TABLE cultivation_parameters (
    param_id VARCHAR(50) PRIMARY KEY,
    run_id VARCHAR(50),
    parameter_name VARCHAR(100),
    parameter_value DECIMAL(10,2),
    unit VARCHAR(20),
    timepoint_days INT,
    FOREIGN KEY (run_id) REFERENCES cultivation_runs(run_id)
);
```

**Key Innovation**: Links cultivation conditions directly to bioactive compound concentrations

**Example Query**:
```sql
-- Find cultivation conditions that maximize erinacine A production
SELECT
    c.temperature_profile,
    c.co2_levels,
    c.substrate_composition,
    AVG(b.concentration_mg_per_g) as avg_erinacine_a
FROM cultivation_runs c
JOIN bioactive_measurements b ON c.run_id = b.run_id
WHERE b.compound_name = 'erinacine_a'
GROUP BY c.temperature_profile, c.co2_levels, c.substrate_composition
ORDER BY avg_erinacine_a DESC
LIMIT 10;
```

---

### 2. Fungal Metabolomics Database (NEW)

**Core Tables**:

```sql
CREATE TABLE mushroom_compounds (
    compound_id VARCHAR(50) PRIMARY KEY,
    compound_name VARCHAR(200),
    iupac_name TEXT,
    common_names TEXT[],
    smiles TEXT,
    inchi_key VARCHAR(50),
    molecular_formula VARCHAR(100),
    molecular_weight DECIMAL(10,4),
    compound_class VARCHAR(100),
    source_species TEXT[],
    source_part VARCHAR(50), -- fruiting_body, mycelium, culture_filtrate
    first_isolated_year INT,
    structural_similarity_to_approved_drugs JSONB
);

CREATE TABLE compound_properties (
    property_id VARCHAR(50) PRIMARY KEY,
    compound_id VARCHAR(50),
    property_name VARCHAR(100),
    property_value TEXT,
    measurement_method VARCHAR(100),
    reference_pmid INT,
    FOREIGN KEY (compound_id) REFERENCES mushroom_compounds(compound_id)
);

-- Links to ChEMBL for known bioactivity
CREATE TABLE compound_chembl_mapping (
    mapping_id VARCHAR(50) PRIMARY KEY,
    compound_id VARCHAR(50), -- Our mushroom compound ID
    chembl_id VARCHAR(50),   -- ChEMBL compound ID
    similarity_score DECIMAL(3,2), -- Tanimoto similarity
    FOREIGN KEY (compound_id) REFERENCES mushroom_compounds(compound_id)
);
```

**Key Innovation**: Bridges mushroom natural products with ChEMBL's bioactivity database

---

### 3. Traditional Use Knowledge Base (NEW)

**Core Tables**:

```sql
CREATE TABLE traditional_uses (
    use_id VARCHAR(50) PRIMARY KEY,
    species VARCHAR(100),
    traditional_name VARCHAR(200),
    culture_region VARCHAR(100),
    historical_use TEXT,
    preparation_method TEXT,
    dosage_traditional TEXT,
    reported_effects TEXT[],
    modern_disease_mapping VARCHAR(100), -- Map to ICD-10 codes
    evidence_quality VARCHAR(20), -- anecdotal, documented, clinical
    earliest_reference_year INT,
    references TEXT[]
);

CREATE TABLE ethnomycology_literature (
    literature_id VARCHAR(50) PRIMARY KEY,
    species VARCHAR(100),
    title TEXT,
    authors TEXT[],
    publication_year INT,
    journal VARCHAR(200),
    traditional_use_description TEXT,
    bioactive_compounds_mentioned TEXT[],
    pmid INT,
    FOREIGN KEY (species) REFERENCES mushroom_species(species_id)
);
```

**Key Innovation**: Connects traditional knowledge with modern pharmaceutical research

**Example Query**:
```sql
-- Find traditional uses that correlate with modern clinical trials
SELECT
    t.species,
    t.traditional_name,
    t.reported_effects,
    t.modern_disease_mapping,
    ct.intervention_name,
    ct.phase,
    ct.primary_outcome
FROM traditional_uses t
JOIN clinical_trials ct ON ct.intervention_name LIKE '%' || t.species || '%'
WHERE t.evidence_quality IN ('documented', 'clinical')
    AND ct.status = 'COMPLETED'
    AND ct.primary_outcome LIKE '%improvement%';
```

---

### 4. Environmental-Bioactivity Correlations (NEW)

**Core Tables**:

```sql
CREATE TABLE cultivation_bioactivity_correlations (
    correlation_id VARCHAR(50) PRIMARY KEY,
    species VARCHAR(100),
    environmental_factor VARCHAR(100), -- temperature, CO2, light, substrate
    factor_value_range VARCHAR(50),
    compound_name VARCHAR(100),
    concentration_change_percent DECIMAL(10,2),
    correlation_coefficient DECIMAL(5,4),
    p_value DECIMAL(10,8),
    sample_size INT,
    study_reference VARCHAR(200)
);

CREATE TABLE optimization_recommendations (
    recommendation_id VARCHAR(50) PRIMARY KEY,
    target_compound VARCHAR(100),
    species VARCHAR(100),
    optimal_temperature_c DECIMAL(5,2),
    optimal_humidity_percent DECIMAL(5,2),
    optimal_co2_ppm INT,
    optimal_substrate VARCHAR(200),
    expected_yield_increase_percent DECIMAL(5,2),
    confidence_level DECIMAL(3,2),
    basis TEXT, -- model-based, experimental, hybrid
    last_updated DATE
);
```

**Key Innovation**: Machine learning-derived optimization for bioactive production

---

## Integration with Standard Pharmaceutical Databases

### ChEMBL Integration

```sql
-- Link mushroom compounds to ChEMBL bioactivity data
CREATE VIEW mushroom_compound_bioactivity AS
SELECT
    mc.compound_name,
    mc.source_species,
    ccm.chembl_id,
    ca.target_chembl_id,
    ca.standard_type,
    ca.standard_value,
    ca.standard_units,
    tp.pref_name as target_name,
    tp.organism
FROM mushroom_compounds mc
JOIN compound_chembl_mapping ccm ON mc.compound_id = ccm.compound_id
JOIN chembl.activities ca ON ccm.chembl_id = ca.molregno
JOIN chembl.target_dictionary tp ON ca.tid = tp.tid
WHERE ca.standard_type IN ('IC50', 'EC50', 'Ki', 'Kd')
    AND ca.data_validity_comment IS NULL;
```

### UniProt Integration

```sql
-- Link targets to protein information
CREATE VIEW mushroom_compound_target_proteins AS
SELECT
    mc.compound_name,
    mc.source_species,
    ca.target_chembl_id,
    up.entry_name,
    up.protein_name,
    up.gene_name,
    up.organism,
    up.function_description,
    up.pathway_involvement
FROM mushroom_compounds mc
JOIN compound_chembl_mapping ccm ON mc.compound_id = ccm.compound_id
JOIN chembl.activities ca ON ccm.chembl_id = ca.molregno
JOIN uniprot.proteins up ON ca.target_chembl_id = up.chembl_target_id;
```

### PubMed/PMC Integration

```sql
-- Link to literature
CREATE VIEW mushroom_research_literature AS
SELECT
    mc.compound_name,
    mc.source_species,
    pmc.pmid,
    pmc.title,
    pmc.abstract,
    pmc.publication_date,
    pmc.journal,
    pmc.keywords
FROM mushroom_compounds mc
JOIN pubmed_articles pmc ON (
    pmc.title LIKE '%' || mc.compound_name || '%' OR
    pmc.abstract LIKE '%' || mc.compound_name || '%' OR
    pmc.title LIKE '%' || mc.source_species[1] || '%'
)
WHERE pmc.publication_date >= '2010-01-01';
```

---

## Unique Use Cases for Mycopharmacology Research

### Use Case 1: Cultivation-Guided Drug Discovery

**Challenge**: Identify optimal cultivation conditions to maximize therapeutic compound production

**Solution**: Query across cultivation + bioactivity + target data

```sql
-- Find cultivation conditions that produce compounds active against Alzheimer's targets
WITH alzheimers_targets AS (
    SELECT target_chembl_id, pref_name
    FROM chembl.target_dictionary
    WHERE organism = 'Homo sapiens'
        AND (pref_name LIKE '%acetylcholinesterase%' OR
             pref_name LIKE '%beta-secretase%' OR
             pref_name LIKE '%tau%')
),
active_compounds AS (
    SELECT DISTINCT ca.molregno, ccm.compound_id
    FROM chembl.activities ca
    JOIN alzheimers_targets at ON ca.tid = at.tid
    JOIN compound_chembl_mapping ccm ON ca.molregno = ccm.chembl_id
    WHERE ca.standard_type = 'IC50'
        AND ca.standard_value < 1000 -- nM, high potency
)
SELECT
    mc.compound_name,
    mc.source_species,
    cr.substrate_composition,
    cr.temperature_profile,
    cr.co2_levels,
    AVG(bm.concentration_mg_per_g) as avg_concentration,
    at.pref_name as alzheimers_target
FROM mushroom_compounds mc
JOIN active_compounds ac ON mc.compound_id = ac.compound_id
JOIN bioactive_measurements bm ON mc.compound_id = bm.compound_name
JOIN cultivation_runs cr ON bm.run_id = cr.run_id
JOIN compound_chembl_mapping ccm ON mc.compound_id = ccm.compound_id
JOIN chembl.activities ca ON ccm.chembl_id = ca.molregno
JOIN alzheimers_targets at ON ca.tid = at.tid
GROUP BY mc.compound_name, mc.source_species, cr.substrate_composition,
         cr.temperature_profile, cr.co2_levels, at.pref_name
ORDER BY avg_concentration DESC;
```

**Output**: Actionable cultivation protocols to maximize Alzheimer's drug candidates

---

### Use Case 2: Traditional Use Validation Pipeline

**Challenge**: Systematically validate traditional mushroom uses with modern pharmacology

**Solution**: Connect traditional use → compounds → targets → clinical evidence

```sql
-- Validate traditional uses of Reishi for liver disease
WITH reishi_compounds AS (
    SELECT compound_id, compound_name
    FROM mushroom_compounds
    WHERE 'Ganoderma lucidum' = ANY(source_species)
),
liver_targets AS (
    SELECT target_chembl_id, pref_name
    FROM chembl.target_dictionary
    WHERE (pref_name LIKE '%liver%' OR pref_name LIKE '%hepat%')
        AND organism = 'Homo sapiens'
)
SELECT
    tu.traditional_name,
    tu.historical_use,
    tu.traditional_culture,
    rc.compound_name,
    ca.standard_type,
    ca.standard_value,
    ca.standard_units,
    lt.pref_name as liver_target,
    COUNT(DISTINCT pmc.pmid) as supporting_publications,
    MAX(ct.phase) as highest_clinical_phase
FROM traditional_uses tu
JOIN reishi_compounds rc ON tu.species LIKE '%Ganoderma%'
JOIN compound_chembl_mapping ccm ON rc.compound_id = ccm.compound_id
JOIN chembl.activities ca ON ccm.chembl_id = ca.molregno
JOIN liver_targets lt ON ca.tid = lt.tid
LEFT JOIN pubmed_articles pmc ON (
    pmc.abstract LIKE '%' || rc.compound_name || '%' AND
    pmc.abstract LIKE '%liver%'
)
LEFT JOIN clinical_trials ct ON ct.intervention_name LIKE '%' || rc.compound_name || '%'
WHERE tu.reported_effects && ARRAY['liver health', 'hepatoprotection']
    AND ca.standard_value < 10000 -- Active threshold
GROUP BY tu.traditional_name, tu.historical_use, tu.traditional_culture,
         rc.compound_name, ca.standard_type, ca.standard_value,
         ca.standard_units, lt.pref_name
ORDER BY supporting_publications DESC;
```

**Output**: Evidence-ranked list of traditional uses with modern validation

---

### Use Case 3: Multi-Target Drug Discovery

**Challenge**: Identify mushroom compounds with polypharmacology potential

**Solution**: Graph-based query across compound-target network

```sql
-- Find mushroom compounds that hit multiple Alzheimer's-relevant targets
WITH alzheimers_pathways AS (
    SELECT DISTINCT target_chembl_id, pref_name, pathway
    FROM (
        VALUES
            ('CHEMBL220', 'Acetylcholinesterase', 'cholinergic'),
            ('CHEMBL4792', 'Beta-secretase 1', 'amyloid'),
            ('CHEMBL4816', 'Glycogen synthase kinase-3 beta', 'tau'),
            ('CHEMBL230', 'Cyclooxygenase-2', 'inflammation'),
            ('CHEMBL1824', 'NMDA receptor', 'excitotoxicity')
    ) AS t(target_chembl_id, pref_name, pathway)
),
compound_target_counts AS (
    SELECT
        mc.compound_id,
        mc.compound_name,
        mc.source_species,
        COUNT(DISTINCT ap.target_chembl_id) as num_targets_hit,
        ARRAY_AGG(DISTINCT ap.pathway) as pathways_affected,
        AVG(ca.standard_value) as avg_potency_nm
    FROM mushroom_compounds mc
    JOIN compound_chembl_mapping ccm ON mc.compound_id = ccm.compound_id
    JOIN chembl.activities ca ON ccm.chembl_id = ca.molregno
    JOIN alzheimers_pathways ap ON ca.tid = ap.tid
    WHERE ca.standard_type = 'IC50'
        AND ca.standard_value < 10000 -- Active
    GROUP BY mc.compound_id, mc.compound_name, mc.source_species
)
SELECT
    ctc.compound_name,
    ctc.source_species,
    ctc.num_targets_hit,
    ctc.pathways_affected,
    ctc.avg_potency_nm,
    cr.substrate_type,
    AVG(bm.concentration_mg_per_g) as avg_yield_mg_per_g,
    STRING_AGG(DISTINCT ap.pref_name, ', ') as specific_targets
FROM compound_target_counts ctc
JOIN mushroom_compounds mc ON ctc.compound_id = mc.compound_id
JOIN compound_chembl_mapping ccm ON mc.compound_id = ccm.compound_id
JOIN chembl.activities ca ON ccm.chembl_id = ca.molregno
JOIN alzheimers_pathways ap ON ca.tid = ap.tid
LEFT JOIN bioactive_measurements bm ON ctc.compound_id = bm.compound_name
LEFT JOIN cultivation_runs cr ON bm.run_id = cr.run_id
WHERE ctc.num_targets_hit >= 3 -- Multi-target threshold
GROUP BY ctc.compound_name, ctc.source_species, ctc.num_targets_hit,
         ctc.pathways_affected, ctc.avg_potency_nm, cr.substrate_type
ORDER BY ctc.num_targets_hit DESC, ctc.avg_potency_nm ASC;
```

**Output**: Polypharmacology candidates with cultivation instructions

---

## AI Integration Layer

### CroweLogic-Pharma Model Training from Knowledge Graph

```python
from knowledge_graph import MycopharmacologyKG

# Initialize knowledge graph
kg = MycopharmacologyKG()

# Generate training examples
training_examples = kg.generate_training_examples([
    'compound_target_pathways',
    'cultivation_optimization',
    'traditional_use_validation',
    'clinical_trial_design',
    'multi_target_discovery'
])

# Example training format
{
    "prompt": "What cultivation conditions optimize ganoderic acid production for hepatocellular carcinoma treatment?",
    "response": """Based on the mycopharmacology knowledge graph:

**Target Disease**: Hepatocellular Carcinoma
**Active Compounds**: Ganoderic Acid A, D (IC50 vs NF-κB: 15-20 μM)
**Optimal Cultivation**:
- Substrate: Oak sawdust + 20% wheat bran
- Temperature: 25-28°C during mycelial growth, 20-23°C for fruiting
- CO2: 800-1200 ppm
- Humidity: 85-95%
- Light: 12h/day, 500-1000 lux
- Expected yield increase: 35% vs standard conditions
- Ganoderic acid concentration: 4.2 mg/g dry weight (vs 2.1 mg/g standard)

**Mechanism**: Ganoderic acids inhibit NF-κB → ↓ IL-6, TNF-α → reduced tumor progression

**Evidence**:
- Cultivation data: 47 runs (p < 0.001)
- ChEMBL activities: 23 assays
- PubMed: 156 publications
- Clinical: Phase II trial ongoing (NCT04521231)""",
    "entities_used": [
        "cultivation_runs",
        "bioactive_measurements",
        "chembl_activities",
        "target_dictionary",
        "pubmed_articles",
        "clinical_trials"
    ],
    "knowledge_graph_path": [
        "disease (hepatocellular_carcinoma)",
        "→ target (nf_kb)",
        "→ compound (ganoderic_acid_a)",
        "→ cultivation_conditions (oak_substrate_optimal)",
        "→ bioactivity_measurements (4.2_mg_g)",
        "→ clinical_evidence (phase_ii)"
    ]
}
```

---

## Implementation Roadmap

### Phase 1: Core Infrastructure (Months 1-3)
- [x] Design schema for mycology-specific tables
- [ ] Ingest existing Southwest Mushrooms cultivation data
- [ ] Map mushroom compounds to ChEMBL/PubChem
- [ ] Build compound-target relationship database
- [ ] Create initial knowledge graph queries

### Phase 2: Data Integration (Months 4-6)
- [ ] Integrate ChEMBL bioactivity data (17,803 targets)
- [ ] Integrate UniProt protein data
- [ ] Ingest PubMed/PMC mycology literature (est. 50,000+ articles)
- [ ] Parse ClinicalTrials.gov for mushroom-related trials
- [ ] Build traditional use knowledge base from ethnomycology literature

### Phase 3: AI Model Training (Months 7-9)
- [ ] Generate 10,000+ training examples from knowledge graph
- [ ] Train CroweLogic-Pharma model on integrated data
- [ ] Develop query-to-answer pipelines
- [ ] Build recommendation systems (cultivation, target identification)
- [ ] Validate predictions against held-out experimental data

### Phase 4: Production Deployment (Months 10-12)
- [ ] Deploy to Azure with knowledge graph backend
- [ ] Build API endpoints for knowledge graph queries
- [ ] Create visualization dashboards
- [ ] Launch researcher portal
- [ ] Publish methodology papers

---

## Competitive Advantages

### 1. **First-Mover Advantage**
No existing platform integrates cultivation data with pharmaceutical databases for mushroom research

### 2. **Proprietary Cultivation Data**
Southwest Mushrooms video library + cultivation logs = unique training data

### 3. **AI-Powered Optimization**
CroweLogic-Pharma model trained specifically on mycopharmacology knowledge graph

### 4. **Traditional Knowledge Integration**
Systematically validates centuries of traditional use with modern pharmacology

### 5. **Reproducible Research**
Complete audit trail from cultivation → compound → target → clinical outcome

---

## Commercialization Strategy

### Target Customers
1. **Pharmaceutical Companies**: Natural product drug discovery divisions
2. **Biotech Startups**: Focus on mushroom/natural product therapeutics
3. **Academic Researchers**: Mycology, pharmacology, drug discovery labs
4. **Mushroom Supplement Companies**: Evidence-based product development
5. **Clinical Research Organizations**: Mushroom clinical trial design

### Pricing Model
- **Academic**: $10K/year (limited queries)
- **Biotech**: $50K/year (full access, API)
- **Pharma**: $200K/year (enterprise, custom integrations)
- **API**: $0.10 per complex query

### Revenue Projections (Year 1)
- 10 academic subscriptions: $100K
- 5 biotech subscriptions: $250K
- 2 pharma subscriptions: $400K
- API usage: $50K
- **Total**: $800K ARR

---

## Technical Stack

### Database
- **PostgreSQL** with graph extensions (Apache AGE)
- **Neo4j** for graph-specific queries
- **Elasticsearch** for full-text literature search

### Cloud Infrastructure
- **Azure**: Primary deployment (already in progress)
- **Azure Database for PostgreSQL**: Knowledge graph storage
- **Azure Cognitive Search**: Literature indexing
- **Azure Machine Learning**: Model training/serving

### API Layer
- **FastAPI**: REST API for knowledge graph queries
- **GraphQL**: For complex multi-hop queries
- **Ollama**: CroweLogic-Pharma model serving

### Visualization
- **Plotly Dash**: Interactive dashboards
- **Cytoscape.js**: Network visualization
- **Observable**: Publication-quality figures

---

## Example API Endpoints

```python
# Knowledge Graph Query API
POST /api/kg/query
{
    "query_type": "cultivation_optimization",
    "target_compound": "erinacine_a",
    "target_disease": "alzheimers_disease",
    "constraints": {
        "substrate_cost": "< $5/kg",
        "cultivation_time": "< 60 days"
    }
}

# Response
{
    "recommendations": [
        {
            "substrate": "oak_sawdust_wheat_bran_80_20",
            "temperature_profile": "20C_mycelial_18C_fruiting",
            "expected_yield": "4.2 mg/g",
            "confidence": 0.87,
            "supporting_runs": 23,
            "cost_estimate": "$3.20/kg",
            "time_to_harvest": "45 days"
        }
    ],
    "target_validation": {
        "target_name": "TrkA receptor",
        "mechanism": "NGF synthesis stimulation",
        "evidence_level": "Phase II clinical trial",
        "chembl_activities": 12,
        "pubmed_citations": 45
    },
    "knowledge_graph_path": [
        "alzheimers_disease → trkA_deficit → ngf_stimulation → erinacine_a →
         optimal_cultivation_conditions → harvest_protocol"
    ]
}
```

---

## Success Metrics

### Technical
- [ ] 100,000+ compound-target relationships mapped
- [ ] 50,000+ cultivation runs integrated
- [ ] 10,000+ training examples generated
- [ ] <2 second query response time
- [ ] 95%+ uptime (Azure SLA)

### Business
- [ ] 20+ paying customers (Year 1)
- [ ] $800K+ ARR (Year 1)
- [ ] 5 peer-reviewed publications
- [ ] 3 pharmaceutical partnerships
- [ ] 100+ validated cultivation protocols

### Scientific Impact
- [ ] 10+ novel compound-target relationships discovered
- [ ] 5+ clinical trials enabled
- [ ] 50%+ reduction in cultivation optimization time
- [ ] 3+ FDA submissions supported

---

## Contact & Collaboration

**Project Lead**: Michael Crowe (michael@crowelogic.com)
**Organization**: CroweLogic-Pharma
**Repository**: https://github.com/MichaelCrowe11/crowelogic-pharma-model
**Documentation**: [In progress]

**Looking for**:
- Pharmaceutical company partnerships
- Academic collaborators
- Funding (Seed round: $2M target)
- Data contributors (cultivation labs, bioactivity screening)

---

## Next Steps

1. **Immediate** (This week):
   - [x] Design knowledge graph schema
   - [ ] Build biomedical knowledge graph extractor script
   - [ ] Run knowledge graph builder
   - [ ] Generate initial training examples

2. **Short-term** (Next month):
   - [ ] Integrate ChEMBL data (17,803 targets)
   - [ ] Parse Southwest Mushrooms cultivation data
   - [ ] Map compounds to ChEMBL IDs
   - [ ] Deploy knowledge graph to Azure PostgreSQL

3. **Medium-term** (Next quarter):
   - [ ] Complete PubMed/PMC integration
   - [ ] Build clinical trials database
   - [ ] Train CroweLogic-Pharma v3 with knowledge graph
   - [ ] Launch beta API for researchers

---

**This framework positions CroweLogic-Pharma as the first and only unified knowledge platform for mushroom pharmaceutical research, creating a significant competitive moat through proprietary data integration and AI-powered insights.**
